National Laboratory Biotechnology Research Act of 2021 This bill directs the Department of Energy (DOE) to establish a National Laboratory Biotechnology Program to integrate the resources of DOE, including the Office of Science, the Office of Intelligence and Counterintelligence, and the National Nuclear Security Administration, to provide research and development and response capabilities to respond to long-term biotechnology threats facing the United States, and any remaining threats posed by COVID-19. The Office of Science shall support research that harnesses the capabilities of the national laboratories to address advanced biological threats of national security significance. The Office of Science shall promote cooperative research and development activities under the program, including collaboration between appropriate industry and academic institutions to promote innovation and the creation of knowledge. No less frequently than biennially, DOE shall develop a strategic research plan under the program.
Advanced technology and technological innovationsBiological and life sciencesCardiovascular and respiratory healthChemical and biological weaponsCongressional oversightDepartment of EnergyEmergency medical services and trauma careExecutive agency funding and structureGeneticsGovernment information and archivesHigher educationInfectious and parasitic diseasesManufacturingMedical researchMinority educationProduct development and innovationPublic-private cooperationResearch administration and fundingResearch and developmentStudent aid and college costsTechnology transfer and commercialization
National Laboratory Biotechnology Research Act of 2021
USA117th CongressS-1624| Senate
| Updated: 5/13/2021
National Laboratory Biotechnology Research Act of 2021 This bill directs the Department of Energy (DOE) to establish a National Laboratory Biotechnology Program to integrate the resources of DOE, including the Office of Science, the Office of Intelligence and Counterintelligence, and the National Nuclear Security Administration, to provide research and development and response capabilities to respond to long-term biotechnology threats facing the United States, and any remaining threats posed by COVID-19. The Office of Science shall support research that harnesses the capabilities of the national laboratories to address advanced biological threats of national security significance. The Office of Science shall promote cooperative research and development activities under the program, including collaboration between appropriate industry and academic institutions to promote innovation and the creation of knowledge. No less frequently than biennially, DOE shall develop a strategic research plan under the program.
Advanced technology and technological innovationsBiological and life sciencesCardiovascular and respiratory healthChemical and biological weaponsCongressional oversightDepartment of EnergyEmergency medical services and trauma careExecutive agency funding and structureGeneticsGovernment information and archivesHigher educationInfectious and parasitic diseasesManufacturingMedical researchMinority educationProduct development and innovationPublic-private cooperationResearch administration and fundingResearch and developmentStudent aid and college costsTechnology transfer and commercialization